NEW YORK (GenomeWeb) – Molecular diagnostics firm MDNA Life Sciences said today that it signed an agreement making Phi Life Sciences the first US distributor of its proprietary liquid biopsy test for prostate cancer, the Prostate Mitomic Test (PMT).
Registering provides access to this and other free content.
Already have an account?Login Now.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.